Jin-Hyoung Kang Selected Research

Jin-Hyoung Kang Research Topics

Disease

26	Neoplasms (Cancer) 07/2021 - 09/2004
25	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2021 - 02/2010
9	Disease Progression 07/2021 - 03/2016
6	Lung Neoplasms (Lung Cancer) 10/2021 - 11/2009
5	Squamous Cell Carcinoma of Head and Neck 10/2020 - 08/2013
5	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2012
4	Neutropenia 01/2019 - 01/2014
4	Carcinoma (Carcinomatosis) 01/2014 - 09/2004
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 01/2012
3	Nausea 10/2017 - 07/2015
3	Adenocarcinoma 05/2016 - 01/2005
3	Head and Neck Neoplasms (Head and Neck Cancer) 10/2015 - 08/2009
2	Hemorrhage 01/2021 - 06/2004
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2020 - 05/2016
2	Anemia 01/2020 - 07/2015
2	Diarrhea 01/2019 - 12/2013
2	Exanthema (Rash) 10/2017 - 12/2013
2	Adenocarcinoma of Lung 07/2013 - 11/2012
2	Carcinogenesis 04/2012 - 01/2007
2	Stomach Neoplasms (Stomach Cancer) 08/2010 - 09/2004
2	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 12/2008 - 06/2008
2	Cholangiocarcinoma 09/2004 - 06/2004
1	Brain Neoplasms (Brain Tumor) 07/2021
1	Hypoxia (Hypoxemia) 11/2020
1	Necrosis 11/2020
1	Nephritis 01/2018
1	Pruritus (Itching) 10/2017
1	Stomatitis 10/2017
1	Fatigue 10/2017
1	Pulmonary Embolism 12/2016
1	Thrombocytopenia (Thrombopenia) 12/2016
1	Febrile Neutropenia 10/2016
1	Vomiting 12/2015

Drug/Important Bio-Agent (IBA)

11	ErbB Receptors (EGF Receptor)IBA 01/2021 - 09/2004
10	Tyrosine Kinase InhibitorsIBA 07/2021 - 10/2011
10	Docetaxel (Taxotere)FDA Link 02/2020 - 02/2010
10	Cisplatin (Platino)FDA LinkGeneric 04/2019 - 06/2004
7	PlatinumIBA 02/2020 - 02/2010
4	Fluorouracil (Carac)FDA LinkGeneric 08/2010 - 06/2004
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2020 - 06/2008
3	Proteins (Proteins, Gene)FDA Link 11/2020 - 09/2010
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2020 - 05/2013
3	Gefitinib (Iressa)FDA Link 08/2012 - 09/2004
2	NivolumabIBA 10/2020 - 10/2017
2	osimertinibIBA 01/2020 - 12/2016
2	Pemetrexed (MTA)FDA Link 04/2019 - 08/2012
2	Pharmaceutical PreparationsIBA 01/2019 - 09/2010
2	Messenger RNA (mRNA)IBA 01/2019 - 09/2010
2	SteroidsIBA 12/2016 - 12/2015
2	Cyclin D1IBA 07/2013 - 09/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 07/2013 - 09/2004
2	Carcinoembryonic AntigenIBA 08/2012 - 06/2008
2	AntigensIBA 08/2012 - 06/2008
2	Gemcitabine FDA Link 12/2011 - 09/2004
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2006 - 09/2004
2	Epirubicin (Ellence)FDA LinkGeneric 01/2005 - 06/2004
1	Taxoids (Taxanes)IBA 10/2021
1	AfatinibIBA 07/2021
1	olmutinibIBA 01/2021
1	CamptothecinIBA 01/2021
1	belotecanIBA 01/2021
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2021
1	AnticoagulantsIBA 01/2021
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2021
1	Hematoxylin (Haematoxylon)IBA 11/2020
1	pimonidazoleIBA 11/2020
1	N- (4- (3- (1H- 1,2,4- triazol- 1- yl)- 4- (3,4,5- trimethoxybenzoyl)phenyl)thiazol- 2- yl)- 2- amino- 3- methylbutanamideIBA 11/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 11/2020
1	TubulinIBA 11/2020
1	Darbepoetin alfa (Aranesp)FDA Link 01/2020
1	Beclin-1IBA 03/2019
1	ParaffinIBA 01/2019
1	nintedanibIBA 01/2019
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2019
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2019
1	Etoposide (VP 16)FDA LinkGeneric 01/2019
1	naquotinibIBA 09/2018
1	KinesinsIBA 03/2018
1	Technetium Tc 99m Dimercaptosuccinic AcidIBA 01/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2017
1	Alanine Transaminase (SGPT)IBA 12/2016
1	RamucirumabIBA 10/2016
1	Matrix Metalloproteinases (MMPs)IBA 05/2016
1	Tissue Inhibitor of Metalloproteinase-1IBA 05/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2016
1	Serotonin ReceptorsIBA 12/2015
1	ramosetron (Nasea)IBA 12/2015
1	Aprepitant (Emend)FDA Link 12/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2015
1	Ondansetron (Zofran)FDA LinkGeneric 12/2015
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 12/2015
1	Cetuximab (Erbitux)FDA Link 10/2015

Therapy/Procedure

14	Therapeutics 01/2021 - 12/2009
14	Drug Therapy (Chemotherapy) 01/2020 - 06/2004
7	Radiotherapy 11/2020 - 06/2008
5	Induction Chemotherapy 02/2020 - 12/2009
5	Chemoradiotherapy 09/2019 - 06/2008
2	Aftercare (After-Treatment) 11/2020 - 12/2011
2	Consolidation Chemotherapy 08/2015 - 03/2011
2	Combination Drug Therapy (Combination Chemotherapy) 12/2011 - 09/2004